Monness, Crespi, Hardt Upgrades Carter's (CRI) to Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Monness, Crespi, Hardt upgraded Carter's (NYSE: CRI) from Neutral to Buy with a price target of $118.00.
Shares of Carter's closed at $100.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carter's (CRI) Misses Q3 EPS by 6c, Guides
- Mizuho Securities Downgrades Community Health (CYH) to Underperform
- Needham & Company Raises Price Target on AXT, Inc. (AXTI) Following 3Q Beat and Guidance
Create E-mail Alert Related CategoriesUpgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!